Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 95 publications
Evolving Landscape of Immunotherapy in Melanoma.
Journal: JCO oncology practice
Published: June 25, 2026
Significance of Gastrointestinal Histiocytosis: A Case Series and Literature Review.
Journal: Cureus
Published: June 05, 2026
Chronic sequelae of immune-related adverse events.
Journal: Expert opinion on drug safety
Published: February 23, 2026
Chronic sequelae of immune-related adverse events.
Journal: Expert opinion on drug safety
Published: February 23, 2026
Cutaneous melanocytic mosaicism with associated melanoma: A case series.
Journal: JAAD case reports
Published: February 09, 2026
Correction: NT-I7, a novel long-acting interleukin-7, promotes anti-PD-1 efficacy in an autologous humanized melanoma model.
Journal: Scientific reports
Published: December 18, 2025
Erratum: Beyond Checkpoint Inhibition: Keeping Therapeutic Options Open.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: August 08, 2025
Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors.
Journal: Journal for immunotherapy of cancer
Published: July 21, 2025
Germline pathogenic variants and immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors.
Journal: Journal of the American Academy of Dermatology
Published: June 06, 2025
Beyond Checkpoint Inhibition: Keeping Therapeutic Options Open.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 15, 2025
Last Updated: 09/26/2026